Santosh Meena's Pharma Sector Analysis Featured by Outlook Business

Indore, July 2026: Santosh Meena, Head of Research at Swastika Investmart Limited, shared his perspective on the sharp decline in pharmaceutical stocks despite clarity around the timeline for proposed US tariff measures. Outlook Business featured his market commentary.

In his analysis, Santosh Meena explained that while the implementation of the proposed tariff measures may be years away, market participants often react to future policy risks well in advance. He noted that investor sentiment, uncertainty over global trade policies, and concerns regarding export-oriented sectors can influence stock prices even before any policy changes take effect.

He further highlighted that pharmaceutical companies continue to possess strong long-term growth drivers, and investors should distinguish between temporary sentiment-driven volatility and structural business fundamentals when evaluating opportunities in the sector.

Santosh Meena regularly shares research-backed market insights covering equities, macroeconomic developments, sectoral trends, and global events that influence Indian financial markets.

Featured In

• Outlook Business – Trump's Tariffs Will Start In 2028; So Why Are Pharma Stocks Falling Today?

About Swastika Investmart Limited

Swastika Investmart Limited (BSE: 530585) is one of India's leading public-listed financial services companies with over three decades of experience in the capital markets. The company offers stockbroking, investment advisory, IPO research, wealth management, commodity and currency trading, and technology-driven investment solutions. Backed by an experienced research team, Swastika Investmart continues to provide timely market insights that help investors make informed financial decisions.